RxSight (RXST) Accumulated Expenses (2020 - 2026)

RxSight (RXST) has 7 years of Accumulated Expenses data on file, last reported at $18.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses rose 28.63% year-over-year to $18.7 million; the trailing twelve-month figure through Mar 2026 stood at $18.7 million (up 28.63% YoY), and the FY2025 full-year result was $19.8 million, down 2.77% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $18.7 million, down from $19.8 million in the prior quarter.
• Across five years, Accumulated Expenses topped out at $20.4 million in Q4 2024 and bottomed at $6.4 million in Q1 2022.
• The 5-year median for Accumulated Expenses is $13.8 million (2024), against an average of $13.8 million.
• The widest annual swing landed in 2022, when Accumulated Expenses soared 70.35%; it then declined 2.77% in 2025.
• A 5-year view of Accumulated Expenses shows it stood at $12.7 million in 2022, then advanced by 20.26% to $15.2 million in 2023, then jumped by 33.59% to $20.4 million in 2024, then retreated by 2.77% to $19.8 million in 2025, then declined by 5.29% to $18.7 million in 2026.
• The last three Accumulated Expenses figures came in at $18.7 million (Q1 2026), $19.8 million (Q4 2025), and $17.6 million (Q3 2025), per Business Quant data.

Peer Comparison